118 related articles for article (PubMed ID: 26674224)
1. CDH1/E-cadherin and solid tumors. An updated gene-disease association analysis using bioinformatics tools.
Abascal MF; Besso MJ; Rosso M; Mencucci MV; Aparicio E; Szapiro G; Furlong LI; Vazquez-Levin MH
Comput Biol Chem; 2016 Feb; 60():9-20. PubMed ID: 26674224
[TBL] [Abstract][Full Text] [Related]
2. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
3. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the human E-cadherin (CDH1) gene.
Berx G; Becker KF; Höfler H; van Roy F
Hum Mutat; 1998; 12(4):226-37. PubMed ID: 9744472
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.
Corso G; Carvalho J; Marrelli D; Vindigni C; Carvalho B; Seruca R; Roviello F; Oliveira C
J Clin Oncol; 2013 Mar; 31(7):868-75. PubMed ID: 23341533
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's disease.
Muise AM; Walters TD; Glowacka WK; Griffiths AM; Ngan BY; Lan H; Xu W; Silverberg MS; Rotin D
Gut; 2009 Aug; 58(8):1121-7. PubMed ID: 19398441
[TBL] [Abstract][Full Text] [Related]
7. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
[TBL] [Abstract][Full Text] [Related]
8. Identification of germline mutations in the cancer predisposing gene CDH1 in patients with orofacial clefts.
Vogelaar IP; Figueiredo J; van Rooij IA; Simões-Correia J; van der Post RS; Melo S; Seruca R; Carels CE; Ligtenberg MJ; Hoogerbrugge N
Hum Mol Genet; 2013 Mar; 22(5):919-26. PubMed ID: 23197654
[TBL] [Abstract][Full Text] [Related]
9. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
10. CDH1 associated gastric cancer: a report of a family and review of the literature.
Moran CJ; Joyce M; McAnena OJ
Eur J Surg Oncol; 2005 Apr; 31(3):259-64. PubMed ID: 15780560
[TBL] [Abstract][Full Text] [Related]
11. Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas.
Zhang XF; Wang YM; Ge H; Cao YY; Chen ZF; Wen DG; Guo W; Wang N; Li Y; Zhang JH
Dis Esophagus; 2008; 21(1):21-9. PubMed ID: 18197935
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
13. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.
Machado JC; Oliveira C; Carvalho R; Soares P; Berx G; Caldas C; Seruca R; Carneiro F; Sobrinho-Simöes M
Oncogene; 2001 Mar; 20(12):1525-8. PubMed ID: 11313896
[TBL] [Abstract][Full Text] [Related]
15. Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples.
Mencucci MV; Lapyckyj L; Rosso M; Besso MJ; Belgorosky D; Isola M; Vanzulli S; Lodillinsky C; Eiján AM; Tejerizo JC; Gonzalez MI; Zubieta ME; Vazquez-Levin MH
Front Oncol; 2020; 10():283. PubMed ID: 32292715
[TBL] [Abstract][Full Text] [Related]
16. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.
Oliveira C; Sousa S; Pinheiro H; Karam R; Bordeira-Carriço R; Senz J; Kaurah P; Carvalho J; Pereira R; Gusmão L; Wen X; Cipriano MA; Yokota J; Carneiro F; Huntsman D; Seruca R
Gastroenterology; 2009 Jun; 136(7):2137-48. PubMed ID: 19269290
[TBL] [Abstract][Full Text] [Related]
17. Association of E-cadherin germ-line alterations with prostate cancer.
Ikonen T; Matikainen M; Mononen N; Hyytinen ER; Helin HJ; Tommola S; Tammela TL; Pukkala E; Schleutker J; Kallioniemi OP; Koivisto PA
Clin Cancer Res; 2001 Nov; 7(11):3465-71. PubMed ID: 11705864
[TBL] [Abstract][Full Text] [Related]
18. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene.
More H; Humar B; Weber W; Ward R; Christian A; Lintott C; Graziano F; Ruzzo AM; Acosta E; Boman B; Harlan M; Ferreira P; Seruca R; Suriano G; Guilford P
Hum Mutat; 2007 Feb; 28(2):203. PubMed ID: 17221870
[TBL] [Abstract][Full Text] [Related]
19. Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma.
Chien MH; Yeh KT; Li YC; Hsieh YH; Lin CH; Weng MS; Kuo WH; Yang SF
J Surg Oncol; 2011 Sep; 104(3):299-304. PubMed ID: 21462191
[TBL] [Abstract][Full Text] [Related]
20. Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome.
Molinaro V; Pensotti V; Marabelli M; Feroce I; Barile M; Pozzi S; Laghi L; Serrano D; Bernard L; Bonanni B; Ranzani GN
Genes Chromosomes Cancer; 2014 May; 53(5):432-45. PubMed ID: 24493355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
